About Insulet
Insulet Corporation (NASDAQ: PODD) is an innovative medical device company founded in 2000 that transforms the lives of people with diabetes through its revolutionary Omnipod insulin delivery system. Born from a father's determination to free his son from the burden of multiple daily insulin injections, Insulet has grown into a global leader in diabetes management technology. The company's flagship product line features tubeless, wearable, waterproof Pod-based insulin management systems that provide continuous insulin delivery without the constraints of traditional tubed pumps. Headquartered in Acton, Massachusetts, with manufacturing facilities and offices around the world, Insulet serves over 600,000 customers across 25 countries in North America, Europe, the Middle East, and Asia Pacific. The company's Omnipod 5 Automated Insulin Delivery System represents a breakthrough in diabetes care as the first truly wearable, automated insulin delivery system controlled by a smartphone. With $2.7 billion in 2025 revenue and recognition as the #1 U.S. requested and prescribed automated insulin delivery (AID) system, Insulet continues to advance its mission of creating a world where diabetes demands less every day, everywhere. The company maintains a strong commitment to quality, safety, and sustainability while continuously innovating to improve outcomes for the diabetes community.
Mission & Story
Mission
Born of empathy, driven by ingenuity, proven by science, we transform the lives of people with diabetes. We envision a world where diabetes demands less every day, everywhere.
Founding Story
The company was founded in 2000 by a father and entrepreneur who looked at his young son's options for insulin delivery and wasn't satisfied. He sketched the first design of Pod therapy on a napkin, paving the way for Insulet's Omnipod technology—a tubeless, wearable, disposable insulin Pod. That legacy of compassion and determination to create something better continues to drive the company today.
Clinical Focus
Medical conditions and clinical areas addressed by Insulet.
Who It Serves
Milestones & Awards
Recent Milestones
Omnipod 5 Automated Insulin Delivery System launched as first truly wearable, automated insulin delivery system controlled by phone. Achieved #1 position for U.S. requested and prescribed AID system. Expanded to 25 countries globally.
Awards & Recognition
#1 U.S. requested and prescribed AID system (2025)
Company Details
- Founded
- 2000
- Headquarters
- Acton, MA, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSimilar Companies in this Market
View all 46 →
Abbott Diabetes Care
Abbott Diabetes Care develops FreeStyle Libre, a world-leading continuous glucose monitoring (CGM) portfolio for diabetes management with advanced analytics and innovation.
Amalgam Rx
Amalgam Rx develops AI-powered digital therapeutics and Software as a Medical Device (SaMD) solutions for chronic disease management. The company partners with life sciences companies, health plans, and providers to deliver regulated digital health applications and EHR-integrated clinical decision support tools.
Arkray
ARKRAY USA manufactures and distributes blood glucose monitoring systems, clinical diagnostic equipment, and oral wellness products. The company serves consumers with diabetes, healthcare professionals, and clinical laboratories with accurate, affordable diagnostic solutions.
BeatO
BeatO is a digital health platform specializing in diabetes management and weight loss solutions. The company offers smart glucose monitoring devices, GLP-1 weight loss programs, and a comprehensive diabetes care program combining connected devices, doctor consultations, and health coaching for over 2 million patients across India.
Brook Health
AI-powered remote patient monitoring and chronic disease management platform for conditions like diabetes, hypertension, and heart disease.
Cadence
Cadence delivers AI-powered remote patient care programs for chronic disease management. The company partners with health systems, payers, and medical groups to provide 24/7 monitoring, medication management, and clinical support for patients with hypertension, heart failure, diabetes, and other chronic conditions.
Cala Health
Cala Health develops the Cala kIQ System, an FDA-cleared wearable device that delivers non-invasive neuromodulation therapy for action hand tremor. The device uses transcutaneous afferent patterned stimulation (TAPS) to provide on-demand tremor relief for people with essential tremor and Parkinson's disease.
Calibrate
Calibrate is a metabolic health company that combines clinician-prescribed GLP-1 medications with 1:1 video coaching and science-backed curriculum to help members achieve sustainable weight loss. Members lose an average of 19% of their body weight achieved over three years.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.